Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mattern

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Critical Reviews in Food Science and Nutrition|February 3, 1998
Tea flavonoids and cardiovascular disease: a reviewL B Tijburg, T Mattern, J D Folts, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitroA Thanhäuser, A Böhle, H D Flad, et al.
Virchows Archiv : an International Journal of Pathology|May 16, 1998
Staining pattern of seven monoclonal anti-CD26 antibodies in leprosy: implications for the use of CD26 as a surrogate marker of a human Th1-like reactionU Seitzer, D Scheel-Toellner, T Mattern, et al.
AIDS (London, England)|September 1, 1994
CD26 is not required for infection of the lymphoma cell line C8166 with HIV-1A Werner, T Mattern, A J Ulmer, et al.
Urological Research|January 1, 1994
On the mode of action of intravesical bacillus Calmette-Guérin: in vitro characterization of BCG-activated killer cellsA Böhle, A Thanhäuser, A J Ulmer, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosyU Seitzer, D Scheel-Toellner, M Hahn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2000
In vitro generation of bacillus Calmette-Guérin-activated killer cellsS Brandau, A Böhle, A Thanhäuser, et al.
AJNR. American Journal of Neuroradiology|August 19, 2007
Sacroplasty versus vertebroplasty: comparable clinical outcomes for the treatment of fracture-related painC T Whitlow, B J Mussat-Whitlow, C W T Mattern, et al.
Immunobiology|August 1, 1993
Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 productionD Reinhold, U Bank, F Bühling, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1995
The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cellsA Thanhäuser, A Böhle, B Schneider, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Critical Reviews in Food Science and Nutrition|February 3, 1998
Tea flavonoids and cardiovascular disease: a reviewL B Tijburg, T Mattern, J D Folts, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitroA Thanhäuser, A Böhle, H D Flad, et al.
Virchows Archiv : an International Journal of Pathology|May 16, 1998
Staining pattern of seven monoclonal anti-CD26 antibodies in leprosy: implications for the use of CD26 as a surrogate marker of a human Th1-like reactionU Seitzer, D Scheel-Toellner, T Mattern, et al.
AIDS (London, England)|September 1, 1994
CD26 is not required for infection of the lymphoma cell line C8166 with HIV-1A Werner, T Mattern, A J Ulmer, et al.
Urological Research|January 1, 1994
On the mode of action of intravesical bacillus Calmette-Guérin: in vitro characterization of BCG-activated killer cellsA Böhle, A Thanhäuser, A J Ulmer, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosyU Seitzer, D Scheel-Toellner, M Hahn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2000
In vitro generation of bacillus Calmette-Guérin-activated killer cellsS Brandau, A Böhle, A Thanhäuser, et al.
AJNR. American Journal of Neuroradiology|August 19, 2007
Sacroplasty versus vertebroplasty: comparable clinical outcomes for the treatment of fracture-related painC T Whitlow, B J Mussat-Whitlow, C W T Mattern, et al.
Immunobiology|August 1, 1993
Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 productionD Reinhold, U Bank, F Bühling, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1995
The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cellsA Thanhäuser, A Böhle, B Schneider, et al.
Pageof 3